Degradable Mesh Implant Void Volume and Strength

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current degradable medical meshes for soft tissue regeneration lack sufficient thickness to provide long-term stability and void volume for tissue augmentation, particularly in applications like breast reconstruction, where they often result in complications such as 'bottoming out' due to limited mechanical strength and rigidity.

Innovation Solution

A degradable medical implant comprising a plurality of porous scaffolds connected by elements allowing mobility, forming a mesh-like structure with a maximum surface area of 500 mm2, enabling adaptability to curved surfaces and providing a larger void volume for tissue regeneration while maintaining mechanical strength through a combination of materials and manufacturing techniques.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If degradable meshes are used for soft tissue regeneration, then tissue regeneration is promoted, but mechanical strength and long-term stability are insufficient

Engineering Contradiction:
Improvetissue regenerationVSAvoidmechanical strength
Core Design Contradiction:
ReliabilityVSStrength

Solution Approach 1:

The patent combines degradable polymer materials with non-degradable or slower-degrading materials to create a composite mesh structure. This allows the mesh to provide sufficient mechanical strength initially while still promoting tissue regeneration, and gradually transitions as the degradable components break down and are replaced by regenerated tissue.

Inventive Principle:
Principle #40Composite materials

2Volume of stationary object

If mesh thickness is increased to provide void volume for tissue augmentation, then tissue regeneration volume is improved, but flexibility and adaptability to curved surfaces deteriorate

Engineering Contradiction:
Improvevoid volumeVSAvoidflexibility
Core Design Contradiction:
Volume of stationary objectVSAdaptability or versatility

Solution Approach 1:

The patent divides the mesh into multiple layers or segments with different thicknesses and porosity characteristics. This segmentation allows certain regions to provide sufficient void volume for tissue augmentation while other regions maintain flexibility and adaptability, particularly in areas that need to conform to curved surfaces.

Inventive Principle:
Principle #1Segmentation

3Object-affected harmful factors

If degradable polymers are used instead of inert materials, then chronic complications are reduced, but mechanical properties are lost too fast

Engineering Contradiction:
Improvechronic complicationsVSAvoidmechanical property duration
Core Design Contradiction:
Object-affected harmful factorsVSDuration of action of stationary object

Solution Approach 1:

The patent modifies the chemical composition and molecular weight of the degradable polymer materials to control their degradation rate. By adjusting parameters such as polymer chain length, cross-linking density, and crystallinity, the mesh maintains adequate mechanical properties throughout the critical healing period while still degrading completely to avoid chronic complications.

Inventive Principle:
Principle #35Parameter changes

4Strength

If mesh rigidity is increased to maintain mechanical strength, then load support capability is improved, but drapeability and ease of implantation deteriorate

Engineering Contradiction:
Improveload support capabilityVSAvoiddrapeability
Core Design Contradiction:
StrengthVSEase of operation

Solution Approach 1:

The patent designs the mesh with dynamic mechanical properties that change over time. Initially, the mesh provides high rigidity and load support capability. As degradation progresses and tissue regeneration occurs, the mesh gradually becomes more compliant, allowing it to adapt to tissue movement and physiological changes while maintaining sufficient structural support throughout the healing process.

Inventive Principle:
Principle #15Dynamics

Data Source

PatentUS11426266B2Medical implant
Publication Date: 2022.08.30 NOVUS SCI
  • US11426266B2 patent drawing
  • US11426266B2 patent drawing

AI summary

The present disclosure is directed to a degradable medical implant (10) for regeneration of soft tissue, comprising a plurality of scaffolds (1), and a plurality of connecting elements (2), wherein each scaffold (1) has a surface projected in the x-y plane, of maximum 500 mm2, and wherein the connecting elements (2) bind the scaffolds (1) together in the x-y plane.